Unfortunately Strychnine (Cat. No. 2785) has been withdrawn from sale for commercial reasons.
If you would like us to consider the re-introduction of this product, or you require a custom synthesis quote for this product, please complete a customer enquiry form and we will contact you as soon as possible.
Find multiple products by catalog number
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.